Thomas G. Mooney, M.D. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2655 Crescent Dr, Suite C, Lafayette, CO 80026 Phone: 303-443-4200 Fax: 303-443-5470 |
Dr. Penney Hsieh, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 200 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 |
Dr. Jennifer Anne Morrison, M.D., PH.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 |
Dr. Eric Benjamin Schwartz, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 |
Dr. Jeanine M Compesi, D.O. Internal Medicine Medicare: Medicare Enrolled Practice Location: 200 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 |
Dr. Michael Robert Williams, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 200 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 |
Dr. Emily Susan Stanton, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 |
Dr. Catherine A Lazar, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 |
News Archive
Marketing is not working well enough to serve the needs of the industry or the changing expectations of the patient. It is time to analyse what we are doing well, and where we need to invest effort and embrace genuine customer engagement. It's time to embrace innovative technologies, improve standard practice and roll out more valuable technologies when justified and create truly integrated, inspiring multichannel engagement campaigns.
Many types of nanoparticles can cross the cell membrane and deliver their therapeutic payload into tumor cells.
Medical Properties Trust, Inc. announced today that it plans to make a public offering of 24 million shares of its common stock. The Company expects to grant the underwriters an option to purchase up to 3.6 million additional shares of common stock to cover over-allotments, if any.
Twenty years of screening for breast and prostate cancer - the most diagnosed cancer for women and men - have not brought the anticipated decline in deaths from these diseases, argue experts from the University of California, San Francisco and the University of Texas Health Science Center at San Antonio in an opinion piece published in the "Journal of the American Medical Association."
The race of kidney donors may affect the survival rates of transplant recipients according to a study by Henry Ford Hospital.
› Verified 7 days ago